A new X-linked variant of chronic granulomatous disease characterized by the existence of a normal clone of respiratory burst-competent phagocytic cells.

Chronic granulomatous disease (CGD) is characterized by recurrent infections, and is usually associated with a complete inability of phagocytic cells to generate superoxide anion (O2-). Rarely, variant forms of CGD have been reported in which there is reduced, but detectable, O2- production by phagocytic cells. We describe three adult males in two kindreds with a unique form of X-linked cytochrome b558-deficient (X91-) CGD not previously reported. All three patients had two distinct populations of phagocytic cells, with one subset capable of normal respiratory burst activity and the other larger subset inactive, as in classic CGD (X91 (0)). The respiratory burst activity in neutrophils purified from each patient was approximately 10% of normal as determined by O2- production, O2 consumption, cytochrome b558 spectroscopy, and membrane oxidase activity using a cell-free activation system. In contrast with other patients with X91(-)-variant CGD, the unique feature of these patients is the presence of a small but significant population (5% to 15%) of circulating neutrophils and monocytes with completely normal respiratory burst activity as assessed by nitroblue tetrazolium (NBT) reduction and flow-cytometric measurement of dihydrorhodamine oxidation. NBT reduction of peripheral blood granulocyte-macrophage progenitor cells also showed the presence of a subset of colonies derived from myeloid progenitor cells that had normal respiratory burst capabilities. A mosaic XX chromosome karyotype and an unstable oxidase complex that might occur during myeloid maturation were both excluded as possible explanations. In these families, the molecular defect in the gp91-phox gene, which is currently under investigation, appears to prevent expression of the gene in the majority of neutrophils, but not in a small subset. Our studies suggest that commitment to either a respiratory burst-competent or -incompetent phagocytic cell occurs at the level of the myeloid progenitor cell.

[1]  P. Hopkins,et al.  Chronic granulomatous disease: diagnosis and classification at the molecular level. , 1992, Clinics in laboratory medicine.

[2]  H. Jaffe,et al.  Prolonged recombinant interferon-gamma therapy in chronic granulomatous disease: evidence against enhanced neutrophil oxidase activity. , 1992, Blood.

[3]  D. Roos,et al.  Chronic granulomatous disease with partial deficiency of cytochrome b 558 and incomplete respiratory burst: variants of the X‐linked, cytochrome b 558–negative form of the disease , 1992, Journal of leukocyte biology.

[4]  P. Newburger,et al.  Chronic granulomatous disease presenting in a 69-year-old man. , 1991, The New England journal of medicine.

[5]  A. Abo,et al.  Activation of the NADPH oxidase involves the small GTP-binding protein p21rac1 , 1991, Nature.

[6]  E. Eklund,et al.  Resolution of a low molecular weight G protein in neutrophil cytosol required for NADPH oxidase activation and reconstitution by recombinant Krev-1 protein. , 1991, The Journal of biological chemistry.

[7]  T Pawson,et al.  SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins. , 1991, Science.

[8]  W. Nauseef,et al.  Neutrophil nicotinamide adenine dinucleotide phosphate oxidase assembly. Translocation of p47-phox and p67-phox requires interaction between p47-phox and cytochrome b558. , 1991, The Journal of clinical investigation.

[9]  R. M. Smith,et al.  Molecular basis of chronic granulomatous disease. , 1991, Blood.

[10]  S. Orkin,et al.  Restoration of phagocyte function by interferon-gamma in X-linked chronic granulomatous disease occurs at the level of a progenitor cell. , 1990, Blood.

[11]  D. Rotrosen,et al.  Evidence for a functional cytoplasmic domain of phagocyte oxidase cytochrome b558. , 1990, The Journal of biological chemistry.

[12]  D. Hassett,et al.  Bacterial adaptation to oxidative stress: implications for pathogenesis and interaction with phagocytic cells , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[13]  S. Orkin,et al.  Association of a Ras-related protein with cytochrome b of human neutrophils , 1989, Nature.

[14]  W. Nauseef,et al.  Genetic variants of chronic granulomatous disease: prevalence of deficiencies of two cytosolic components of the NADPH oxidase system. , 1989, The New England journal of medicine.

[15]  J. Donelson,et al.  Cloning of the cDNA and functional expression of the 47-kilodalton cytosolic component of human neutrophil respiratory burst oxidase. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[16]  S. Orkin,et al.  Absence of both the 91kD and 22kD subunits of human neutrophil cytochrome b in two genetic forms of chronic granulomatous disease. , 1989, Blood.

[17]  J. Curnutte,et al.  Cytosolic components of the respiratory burst oxidase: resolution of four components, two of which are missing in complementing types of chronic granulomatous disease. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[18]  S. Orkin,et al.  Partial Correction of the Phagocyte Defect in Patients with X-Linked Chronic Granulomatous Disease by Subcutaneous Interferon Gamma , 1988 .

[19]  S. Orkin,et al.  Primary structure and unique expression of the 22-kilodalton light chain of human neutrophil cytochrome b. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[20]  S. Shurin,et al.  Chronic granulomatous disease due to a defect in the cytosolic factor required for nicotinamide adenine dinucleotide phosphate oxidase activation. , 1988, The Journal of clinical investigation.

[21]  M. Daly,et al.  A genetic linkage map of the human genome , 1987, Cell.

[22]  A. Jesaitis,et al.  Purified cytochrome b from human granulocyte plasma membrane is comprised of two polypeptides with relative molecular weights of 91,000 and 22,000. , 1987, The Journal of clinical investigation.

[23]  J. Curnutte,et al.  Activation of neutrophil NADPH oxidase in a cell-free system. Partial purification of components and characterization of the activation process. , 1987, The Journal of biological chemistry.

[24]  A. Segal Absence of both cytochrome b−245 subunits from neutrophils in X-linked chronic granulomatous disease , 1987, Nature.

[25]  P. Newburger,et al.  Variant chronic granulomatous disease: modulation of the neutrophil defect by severe infection. , 1986, Blood.

[26]  J. Haines,et al.  DNA linkage analysis of X chromosome-linked chronic granulomatous disease. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[27]  S. Al‐Awadi,et al.  Klinefelter's syndrome, mosaic 46,XX/46,XY/47,XXY/48,XXXY/48,XXYY: a case report. , 1986, Annales de genetique.

[28]  M. Klempner,et al.  Late-presenting variant of chronic granulomatous disease. , 1984, Pediatric infectious disease.

[29]  J. A. Badwey,et al.  Studies on the mechanism of superoxide release from human neutrophils stimulated with arachidonate. , 1984, The Journal of biological chemistry.

[30]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[31]  A. Feinberg,et al.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. , 1983, Analytical biochemistry.

[32]  A. Segal,et al.  A variant form of X‐linked chronic granulomatous disease with normal nitroblue tetrazolium slide test and cytochrome b , 1983, European journal of clinical investigation.

[33]  M. Seeds,et al.  Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation. , 1983, Journal of immunology.

[34]  P. Newburger,et al.  Chronic granulomatous disease due to granulocytes with abnormal NADPH oxidase activity and deficient cytochrome-b. , 1983, Blood.

[35]  M. L. Karnovsky,et al.  Cytochalasin E diminishes the lag phase in the release of superoxide by human neutrophils. , 1982, Biochemical and biophysical research communications.

[36]  T. Stossel,et al.  A variant of chronic granulomatous disease: deficient oxidative metabolism due to a low-affinity NADPH oxidase. , 1981, The New England journal of medicine.

[37]  P. Newburger,et al.  Chronic granulomatous disease. Expression of the metabolic defect by in vitro culture of bone marrow progenitors. , 1980, The Journal of clinical investigation.

[38]  P. Quie,et al.  X-linked inheritance in females with chronic granulomatous disease. , 1980, The Journal of clinical investigation.

[39]  T. Stossel,et al.  An inherited abnormality of neutrophil adhesion. Its genetic transmission and its association with a missing protein. , 1980, The New England journal of medicine.

[40]  T. Stossel,et al.  Functional Immaturity of Bone Marrow Bands and Polymorphonuclear Leucocytes , 1974, British journal of haematology.

[41]  A. Bøyum,et al.  Isolation of mononuclear cells and granulocytes from human blood. , 1968 .